The AffiELISA® Human IMA Kit uses competitive inhibition enzyme immunoassay technique. The provided microtiter plate comes pre-coated with Ischemia Modified Albumin (IMA) protein. To perform the assay, standards or samples are added to designated wells on the microtiter plate. Subsequently, a biotin-conjugated antibody specific to Ischemia Modified Albumin (IMA) is introduced. Avidin conjugated to Horseradish Peroxidase (HRP) is then added to each well, followed by an incubation period. Afterward, the TMB substrate solution is added, initiating an enzyme-substrate reaction. To conclude the reaction, a sulphuric acid solution is introduced, causing a color change that can be measured spectrophotometrically at a wavelength of 450nm ± 10nm. By comparing the optical density (OD) of the samples to the standard curve, the concentration of Ischemia Modified Albumin (IMA) in the samples can be determined.
AffiELISA® Human IMA Kit
Ischemia Modified Albumin
Human
Competitive Inhibition ELISA
Serum, plasma and other biological fluids
Metabolic pathway, Cardiovascular biology.